
Azacitidine Suppliers & Bulk Manufacturers
Available Forms: Injectable
Available Strengths: 100 mg/vial
Reference Brands: Vidaza®(EU & US)
Category: Oncology Cancer Care
Azacitidine is available in Injectable and strengths such as 100 mg/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Azacitidine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Azacitidine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Azacitidine 50 mg and 100 mg Vials are essential treatments for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Available under the brand name Vidaza®, Azacitidine is a hypomethylating agent that plays a critical role in restoring normal blood cell production in patients with MDS or AML. It works by inhibiting DNA methylation, leading to the reactivation of growth-controlling genes. Azacitidine is available in subcutaneous and intravenous injection forms in 50 mg and 100 mg vials, and is crucial in oncology B2B portfolios focused on blood cancers and hematologic malignancies.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers